Literature DB >> 29861117

Organ-preserving approaches in oesophageal cancer.

Rebecca C Fitzgerald1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29861117      PMCID: PMC6078177          DOI: 10.1016/S1470-2045(18)30291-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  10 in total

1.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

2.  Inter-Observer Agreement among Pathologists Using Wide-Area Transepithelial Sampling With Computer-Assisted Analysis in Patients With Barrett's Esophagus.

Authors:  Prashanth R Vennalaganti; Vijay Naag Kanakadandi; Seth A Gross; Sravanthi Parasa; Kenneth K Wang; Neil Gupta; Prateek Sharma
Journal:  Am J Gastroenterol       Date:  2015-04-28       Impact factor: 10.864

3.  Range of pathologies diagnosed using a minimally invasive capsule sponge to evaluate patients with reflux symptoms.

Authors:  Anna L Paterson; Pierre Lao-Sirieix; Maria O'Donovan; Irene Debiram-Beecham; Massimiliano di Pietro; Ahmad Miremadi; Stephen E Attwood; Fiona M Walter; Peter D Sasieni; Rebecca C Fitzgerald
Journal:  Histopathology       Date:  2016-10-12       Impact factor: 5.087

4.  Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

Authors:  Katrin M Sjoquist; Bryan H Burmeister; B Mark Smithers; John R Zalcberg; R John Simes; Andrew Barbour; Val Gebski
Journal:  Lancet Oncol       Date:  2011-06-16       Impact factor: 41.316

5.  Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.

Authors:  Bo Jan Noordman; Manon C W Spaander; Roelf Valkema; Bas P L Wijnhoven; Mark I van Berge Henegouwen; Joël Shapiro; Katharina Biermann; Ate van der Gaast; Richard van Hillegersberg; Maarten C C M Hulshof; Kausilia K Krishnadath; Sjoerd M Lagarde; Grard A P Nieuwenhuijzen; Liekele E Oostenbrug; Peter D Siersema; Erik J Schoon; Meindert N Sosef; Ewout W Steyerberg; J Jan B van Lanschot
Journal:  Lancet Oncol       Date:  2018-06-01       Impact factor: 41.316

Review 6.  Interim 18F-FDG-PET/CT during chemo-radiotherapy in the management of oesophageal cancer patients. A systematic review.

Authors:  Marta Cremonesi; Cristina Garibaldi; Robert Timmerman; Mahila Ferrari; Sara Ronchi; Chiara Maria Grana; Laura Travaini; Laura Gilardi; Anna Starzyńska; Delia Ciardo; Roberto Orecchia; Barbara Alicja Jereczek-Fossa; Maria Cristina Leonardi
Journal:  Radiother Oncol       Date:  2017-10-10       Impact factor: 6.280

7.  Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer.

Authors:  Kazuki Sudo; Lianchun Xiao; Roopma Wadhwa; Hironori Shiozaki; Elena Elimova; Takashi Taketa; Mariela A Blum; Jeffrey H Lee; Manoop S Bhutani; Brian Weston; William A Ross; Ritsuko Komaki; David C Rice; Stephen G Swisher; Wayne L Hofstetter; Dipen M Maru; Heath D Skinner; Jaffer A Ajani
Journal:  J Clin Oncol       Date:  2014-09-15       Impact factor: 44.544

Review 8.  Oesophageal cancer.

Authors:  Elizabeth C Smyth; Jesper Lagergren; Rebecca C Fitzgerald; Florian Lordick; Manish A Shah; Pernilla Lagergren; David Cunningham
Journal:  Nat Rev Dis Primers       Date:  2017-07-27       Impact factor: 52.329

9.  Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor 3 expression for diagnosing Barrett's esophagus: a multi-center case-control study.

Authors:  Caryn S Ross-Innes; Irene Debiram-Beecham; Maria O'Donovan; Elaine Walker; Sibu Varghese; Pierre Lao-Sirieix; Laurence Lovat; Michael Griffin; Krish Ragunath; Rehan Haidry; Sarmed S Sami; Philip Kaye; Marco Novelli; Babett Disep; Richard Ostler; Benoit Aigret; Bernard V North; Pradeep Bhandari; Adam Haycock; Danielle Morris; Stephen Attwood; Anjan Dhar; Colin Rees; Matthew D D Rutter; Peter D Sasieni; Rebecca C Fitzgerald
Journal:  PLoS Med       Date:  2015-01-29       Impact factor: 11.069

10.  Detection and localization of surgically resectable cancers with a multi-analyte blood test.

Authors:  Joshua D Cohen; Lu Li; Yuxuan Wang; Christopher Thoburn; Bahman Afsari; Ludmila Danilova; Christopher Douville; Ammar A Javed; Fay Wong; Austin Mattox; Ralph H Hruban; Christopher L Wolfgang; Michael G Goggins; Marco Dal Molin; Tian-Li Wang; Richard Roden; Alison P Klein; Janine Ptak; Lisa Dobbyn; Joy Schaefer; Natalie Silliman; Maria Popoli; Joshua T Vogelstein; James D Browne; Robert E Schoen; Randall E Brand; Jeanne Tie; Peter Gibbs; Hui-Li Wong; Aaron S Mansfield; Jin Jen; Samir M Hanash; Massimo Falconi; Peter J Allen; Shibin Zhou; Chetan Bettegowda; Luis A Diaz; Cristian Tomasetti; Kenneth W Kinzler; Bert Vogelstein; Anne Marie Lennon; Nickolas Papadopoulos
Journal:  Science       Date:  2018-01-18       Impact factor: 47.728

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.